je.st
news
Home
› JHL Biotech, Inc. And Selexis SA Form Biologic Drug Development Alliance To Serve The Biopharmaceutical Industry
JHL Biotech, Inc. And Selexis SA Form Biologic Drug Development Alliance To Serve The Biopharmaceutical Industry
2013-12-04 05:10:37| drugdiscoveryonline News Articles
JHL Biotech, Inc., a provider of biopharmaceutical process development and manufacturing services, and Switzerland-based Selexis SA, a provider of technologies for mammalian cell line development, announced today that they have signed a non-exclusive strategic agreement to provide biopharmaceutical customers a seamless solution for the development and cGMP manufacturing of biologic drugs
Tags: the
form
development
industry
Category:Biotechnology and Pharmaceuticals